المؤلفون: RH Borse, PH Hu, K Ramakrishnan, C Black

المصدر: Value in Health. 25:S59-S60

مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::85257ebca4f9484c7f2faa6fddfe596d
https://doi.org/10.1016/j.jval.2021.11.275

المؤلفون: R Minacori, M Apert, S Leproust, R Monnier, RO Casasnovas, P Brice, RH Borse, J Gandhi, A Rai

المصدر: Value in Health. 25:S55

مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7ee3d3b9d5aa9040bed560fa2a3b0fae
https://doi.org/10.1016/j.jval.2021.11.254

المؤلفون: Borse RH; Merck & Co., Inc., Kenilworth, NJ, USA., Ramakrishnan K; Merck & Co., Inc., Kenilworth, NJ, USA., Gandhi J; CHEORS, North Wales, PA, USA., Dhankhar P; CHEORS, North Wales, PA, USA., Chirovsky D; Merck & Co., Inc., Kenilworth, NJ, USA.

المصدر: Journal of medical economics [J Med Econ] 2022 Jan-Dec; Vol. 25 (1), pp. 954-965.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

مواضيع طبية MeSH: Cisplatin*/therapeutic use , Head and Neck Neoplasms*/drug therapy, Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cetuximab ; Cost-Benefit Analysis ; Fluorouracil ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Paclitaxel/therapeutic use ; Platinum ; Quality of Life ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; United States

المؤلفون: Svedbom A; Real-World Strategy and Analytics, ICON Clinical Research, Stockholm, Sweden., Dalén J; Real-World Strategy and Analytics, ICON Clinical Research, Stockholm, Sweden., Ivergård M; Real-World Strategy and Analytics, ICON Clinical Research, Stockholm, Sweden., Borse RH; Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA., Black CM; Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA., Luttropp K; Real-World Strategy and Analytics, ICON Clinical Research, Stockholm, Sweden., Kachroo S; Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA. sumesh.kachroo@merck.com.

المصدر: The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2020 Feb; Vol. 21 (1), pp. 45-54. Date of Electronic Publication: 2019 Sep 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE

مواضيع طبية MeSH: Medication Adherence/*statistics & numerical data , Spondylitis, Ankylosing/*drug therapy , Tumor Necrosis Factor Inhibitors/*economics , Tumor Necrosis Factor Inhibitors/*therapeutic use, Cost-Benefit Analysis ; Female ; Humans ; Injections, Subcutaneous ; Male ; Markov Chains ; Models, Econometric ; Quality-Adjusted Life Years ; Severity of Illness Index ; Tumor Necrosis Factor Inhibitors/administration & dosage ; United Kingdom

المؤلفون: Large S; a PAREXEL International , London , UK., Hettle R; a PAREXEL International , London , UK., Balakumaran A; b Merck & Co., Inc. , Kenilworth , NJ , USA., Wu E; b Merck & Co., Inc. , Kenilworth , NJ , USA., Borse RH; b Merck & Co., Inc. , Kenilworth , NJ , USA.

المصدر: Journal of medical economics [J Med Econ] 2018 Nov 13, pp. 1-10. Date of Electronic Publication: 2018 Nov 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ

المؤلفون: Borse RH; Merck & Co., Inc., Kenilworth, NJ, USA. rebekah.borse@merck.com., Kachroo S; Merck & Co., Inc., Kenilworth, NJ, USA., Brown C; Merck Sharp & Dohme, Hoddesdon, UK., McCann E; Merck Sharp & Dohme, Hoddesdon, UK., Insinga RP; Merck & Co., Inc., Kenilworth, NJ, USA.

المصدر: Rheumatology and therapy [Rheumatol Ther] 2018 Jun; Vol. 5 (1), pp. 57-73. Date of Electronic Publication: 2018 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Healthcare Country of Publication: England NLM ID: 101674543 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2198-6576 (Print) Linking ISSN: 21986576 NLM ISO Abbreviation: Rheumatol Ther Subsets: PubMed not MEDLINE

المؤلفون: Borse RH; Division of Preparedness and Emerging Infections, National Center of Emerging & Zoonotic Diseases, CDC, Atlanta, Georgia, United States of America., Atkins CY; Division of Preparedness and Emerging Infections, National Center of Emerging & Zoonotic Diseases, CDC, Atlanta, Georgia, United States of America., Gambhir M; Division of Preparedness and Emerging Infections, National Center of Emerging & Zoonotic Diseases, CDC, Atlanta, Georgia, United States of America., Undurraga EA; Division of Preparedness and Emerging Infections, National Center of Emerging & Zoonotic Diseases, CDC, Atlanta, Georgia, United States of America., Blanton JD; Poxvirus And Rabies Branch, Division of High-Consequence Pathogens and Pathology National Center of Emerging & Zoonotic Diseases, CDC, Atlanta, Georgia, United States of America., Kahn EB; Division of Preparedness and Emerging Infections, National Center of Emerging & Zoonotic Diseases, CDC, Atlanta, Georgia, United States of America., Dyer JL; Poxvirus And Rabies Branch, Division of High-Consequence Pathogens and Pathology National Center of Emerging & Zoonotic Diseases, CDC, Atlanta, Georgia, United States of America., Rupprecht CE; Poxvirus And Rabies Branch, Division of High-Consequence Pathogens and Pathology National Center of Emerging & Zoonotic Diseases, CDC, Atlanta, Georgia, United States of America., Meltzer MI; Division of Preparedness and Emerging Infections, National Center of Emerging & Zoonotic Diseases, CDC, Atlanta, Georgia, United States of America.

المصدر: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 May 23; Vol. 12 (5), pp. e0006490. Date of Electronic Publication: 2018 May 23 (Print Publication: 2018).

نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE

مواضيع طبية MeSH: Dog Diseases/*economics , Dog Diseases/*prevention & control , Immunization Programs/*economics , Rabies/*prevention & control , Rabies Vaccines/*economics , Vaccination/*economics, Africa, Eastern ; Animals ; Cost-Benefit Analysis ; Dog Diseases/mortality ; Dog Diseases/transmission ; Dogs ; Female ; Humans ; Immunization Programs/methods ; Male ; Models, Theoretical ; Rabies/economics ; Rabies/mortality ; Rabies/transmission ; Rabies Vaccines/administration & dosage

المؤلفون: Borse RH; Merck Research Laboratories (MRL), Merck & Co., Inc., Kenilworth, NJ, USA. rebekah.borse@merck.com., Brown C; MSD Ltd, Hoddesdon, UK., Muszbek N; Evidera, London, UK., Chaudhary MA; Merck Research Laboratories (MRL), Merck & Co., Inc., Kenilworth, NJ, USA., Kachroo S; Merck Research Laboratories (MRL), Merck & Co., Inc., Kenilworth, NJ, USA.

المصدر: Rheumatology and therapy [Rheumatol Ther] 2017 Dec; Vol. 4 (2), pp. 427-443. Date of Electronic Publication: 2017 Sep 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Healthcare Country of Publication: England NLM ID: 101674543 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2198-6576 (Print) Linking ISSN: 21986576 NLM ISO Abbreviation: Rheumatol Ther Subsets: PubMed not MEDLINE

المؤلفون: Prabhu VS; Merck & Co., Inc., Kenilworth, NJ USA.; Center for Observational and Real World Evidence (CORE), Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033 USA., Solomkin JS; University of Cincinnati College of Medicine, Cincinnati, OH USA., Medic G; Mapi Group, Houten, The Netherlands., Foo J; Mapi Group, Houten, The Netherlands., Borse RH; Merck & Co., Inc., Kenilworth, NJ USA., Kauf T; Baxalta US Inc., Boston, MA USA., Miller B; Shire, Lexington, MA USA., Sen SS; Merck & Co., Inc., Kenilworth, NJ USA., Basu A; Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA USA.

المصدر: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2017 Oct 27; Vol. 6, pp. 107. Date of Electronic Publication: 2017 Oct 27 (Print Publication: 2017).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101585411 Publication Model: eCollection Cited Medium: Internet ISSN: 2047-2994 (Electronic) Linking ISSN: 20472994 NLM ISO Abbreviation: Antimicrob Resist Infect Control Subsets: PubMed not MEDLINE

المؤلفون: Kauf TL; Shire International GmbH, Zug, Switzerland., Prabhu VS; Merck & Co., Inc., Kenilworth, NJ, USA. vimalanand.prabhu@merck.com.; Merck & Co., Inc., 2000 Galloping Hill Rd., Kenilworth, NJ, 07033, USA. vimalanand.prabhu@merck.com., Medic G; MAPI Group, Houten, The Netherlands., Borse RH; Merck & Co., Inc., Kenilworth, NJ, USA., Miller B; Shire, Lexington, MA, USA., Gaultney J; MAPI Group, Houten, The Netherlands., Sen SS; Merck & Co., Inc., Kenilworth, NJ, USA., Basu A; University of Washington, Seattle, WA, USA.

المصدر: BMC infectious diseases [BMC Infect Dis] 2017 Apr 28; Vol. 17 (1), pp. 314. Date of Electronic Publication: 2017 Apr 28.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Bacterial Agents/*economics , Anti-Bacterial Agents/*therapeutic use , Penicillanic Acid/*analogs & derivatives , Urinary Tract Infections/*drug therapy , Urinary Tract Infections/*economics, Adult ; Cephalosporins/economics ; Cephalosporins/therapeutic use ; Cost-Benefit Analysis ; Hospitalization/economics ; Humans ; Middle Aged ; Monte Carlo Method ; Mortality ; Penicillanic Acid/economics ; Penicillanic Acid/therapeutic use ; Piperacillin/economics ; Piperacillin/therapeutic use ; Piperacillin, Tazobactam Drug Combination ; Quality-Adjusted Life Years ; United States ; Urinary Tract Infections/complications ; Urinary Tract Infections/microbiology